Sindromul de hiperstimulare ovariană (OHSS): prevenție, simptome și tratament
Dr. Mihaela BragaOHSS în FIV: factori de risc, clasificare ușoară/moderată/severă, simptome, strategii de prevenire (trigger agonist, coasting, freeze-all) și management.
Întrebări frecvente
Humaidan P, Quartarolo J, Papanikolaou EG Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertility and Sterility, 2010.
DOI: 10.1016/j.fertnstert.2010.01.080Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering. Cochrane Database of Systematic Reviews, 2014.
DOI: 10.1002/14651858.CD008046.pub4Alvarez C, Alonso-Muriel I, Garcia G, Crespo J Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women. The Journal of Clinical Endocrinology & Metabolism, 2007.
DOI: 10.1210/jc.2007-0580Practice Committee of the ASRM Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome. Fertility and Sterility, 2016.
DOI: 10.1016/j.fertnstert.2016.08.048Nastri CO, Teixeira DM, Moroni RM, Leitao VM, Martins WP Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention. Ultrasound in Obstetrics & Gynecology, 2015.
DOI: 10.1002/uog.14684Mourad S, Brown J, Farquhar C Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. Cochrane Database of Systematic Reviews, 2017.
DOI: 10.1002/14651858.CD012103.pub2Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E Ovarian hyperstimulation syndrome: an update review. Obstetrical & Gynecological Survey, 1989.
DOI: 10.1097/00006254-198906000-00001Aboulghar MA, Mansour RT Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Human Reproduction Update, 2003.
DOI: 10.1093/humupd/dmg018
